9th Annual Biomarkers Congress
Stem Cells for Drug Developers
Revere Hotel Boston Common
200 Stuart Street
Boston, USA
http://stemcells-drugdevelopment.com/
Stem Cells for Drug Developers
Revere Hotel Boston Common
200 Stuart Street
Boston
USA
http://stemcells-drugdevelopment.com/

Schedule of Presentations:

Tuesday, March 19, 2013
06:00:00 New Presentation
09:00:00 The Challenges of Incorporating Multiple Differentiated Cell Types from Patient Derived iPS Cells to Definitively Model Diseased Tissues John Hambor
13:00:00 Developing High Content Screening Tools Using Patient Specific iPS Cells to Discover Novel Therapeutic Compounds
Wednesday, March 20, 2013
07:45:00 Registration, Coffee & Networking
08:25:00 Chair’s Opening Remarks Gary A. Gintant
08:30:00 Developing Drug Discovery Programs Using Pluripotent Stem Cells: A Pharma Insider’s Four Year Perspective
09:00:00 Using Stem Cell Derived Cells to Develop More Predictive Assays
09:30:00 Characterization and Utilization of iPS Derived Cardiomyocytes in Early Predictive Screening Dinesh Puppala
10:00:00 Speed Networking Session & Morning Refreshments
10:30:00 Validation of an iPSC Based Drug Screening Platform to be Used to Identify Novel Small Molecules Active in Promoting Chondrogenesis Paul August
11:30:00 Using Stem Cell-Derived Cardiomyocytes as Novel In Vitro Models to Study Human Cardiac Toxicity
12:00:00 ESCs and iPSCs as Simple, Reproducible and Cost-Effective Tools for Toxicity Testing Hirdesh Uppal
12:30:00 Lunch & Networking
14:00:00 Validating Stem Cell-Based Assays and Models for Drug Safety and Discovery Gary A. Gintant
14:30:00 Round Table Discussion: How can Pharma Validate Stem Cell-Derived Models as Being Better than Current Models for Screening and Tox Studies?
15:00:00 Afternoon Refreshments & Networking
15:30:00 Using ESC Models as a Tool for Therapeutic Target Discovery Wojtek Auerbach
16:00:00 Phenotypic Screening Using Stem-Cell Derived Mature Cardiomyocytes to Identify Novel Therapeutic Targets Christine Ivashchenko
16:30:00 Pluripotent Stem Cell-Derived Hepatocytes Recapitulate the Pathophysiology of Familial Hypercholesterolemia
17:00:00 Chair’s Closing Remark
Thursday, March 21, 2013
06:00:00 New Presentation
08:00:00 Registration, Coffee & Networking
08:55:00 Chair’s Opening Remarks Ilyas Singec
09:00:00 Keynote Efficient Generation of Potent Vasculogenic Cells Rakesh K Jain
09:30:00 New Approaches to Create a 3D Retinal Disease Model Deepak Lamba
10:00:00 Round Table Discussion: Gaining Access to Patient Samples and Using Stem Cell Lines
10:30:00 Morning Refreshments & Networking
11:00:00 A Defined and Robust In Vitro System to Differentiate hESCs/iPSCs into Functional Blood Cells
11:30:00 Industrial Approach for Neuronal Differentiation of Patient Derived iPS cells for Modeling Alzheimer's Disease
12:00:00 Patient iPSCs as a Model for Accelerated Cardiovascular Disease Drug Discovery Roberto Iacone
12:30:00 Lunch & Networking
13:30:00 Towards a Pancreatic Cell Fate: Strategies for Characterization and Function
14:00:00 Phospho-Proteomic Profiling of Neural Lineage Entry Using Human Pluripotent Stem Cells Ilyas Singec
15:00:00 Therapeutic Potential of Pluripotent Stem Cells for Muscular Dystrophies Radbod Darabi
15:30:00 Round Table Discussion: Filling a Need in the Market Place: What Terminally Differentiated Cell Types should we be Prioritizing?
16:00:00 Chair’s Closing Remarks
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.